The MCF-7 breast cancer cell line and the HeLa cervical cancer cell line were used as they both showed G9A upregulation compared to normal tissues (S1 Fig) and are consistent with the patient data from GENT (Fig 1A). This evidence concerns the gene EHMT2 and cervical carcinoma.